Ref. Ares(2022)35254 - 04/01/2022
Ref. Ares(2022)3545646 - 10/05/2022
Art. 4.1(b)
From:
Art. 4.1(b)
Sent:
jeudi 7 octobre 2021 13:44
To:
Art. 4.1(b)
Subject:
Moderna to set up vaccine production facility in Africa
Follow Up Flag:
Follow up
Flag Status:
Flagged
Dear Art. 4.1(b)
In light of the discussions on production and IP of vaccines, maybe the below information is important at this
stage (showing a measure that does work to help against COVID and future pandemics). Of course you may
already be aware of this:
https://www.businesswire.com/news/home/20211006006058/en/Moderna-to-Build-State-of-the-Art-mRNA-
Facility-in-Africa-to-Manufacture-up-to-500-Million-Doses-Per-Year
Best,
Art. 4.1(b)
--
Art. 4.1(b)
Executive Director for International Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations
Leopold Plaza Building
Rue du TrĂ´ne 108
B-1050 Bruxelles
Art. 4.1(b)
1